Chronic Neurological Diseases and Covid-19: Associations and Considerations Publisher



Meshkat S² ; Salimi A³ ; Joshaghanian A⁴ ; Sedighi S⁵ ; Sedighi S⁵ ; Aghamollaii V¹ Show Affiliations
Source: Translational Neuroscience Published:2020

Abstract

The 2019 novel coronavirus pandemic, severe acute respiratory syndrome CoV-2 (COVID-19), has been a worldwide urgent public health threat, resulting in sixhundred seventy thousand deaths to date. The COVID-19 pandemic has led to a series of public health challenges. One such challenge is the management of diseases such as chronic neurological diseases during an epidemic event. COVID-19 affects all kinds of people, including older people with chronic underlying diseases, who are particularly at risk of severe infection or even death. Chronic neurological diseases such as epilepsy, dementia, Parkinson's disease (PD), and multiple sclerosis (MS) are frequently associated with comorbidities; thus, these patients are in the high-risk category. Therefore, in this article, we review associations and challenges the people with epilepsy, dementia, PD, and MS faces during the COVID-19 pandemic and suggest approaches to provide consensus recommendations on how to provide the best possible care. © 2020 Shakila Meshkat et al., published by De Gruyter.